Panion & Bf Biotech Inc. (1760.TW)
TWD 67.3
(2.75%)
TWD 67.3
(2.75%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 125.41 Million TWD | 117.37% |
| 2022 | 57.69 Million TWD | -65.62% |
| 2021 | 167.84 Million TWD | -77.45% |
| 2020 | 744.23 Million TWD | 778.34% |
| 2019 | 84.73 Million TWD | 0.0% |
| 2018 | - TWD | 0.0% |
| 2017 | - TWD | 0.0% |
| 2016 | - TWD | 0.0% |
| 2015 | - TWD | 0.0% |
| 2014 | - TWD | 0.0% |
| 2013 | - TWD | -100.0% |
| 2012 | 122.38 Million TWD | -7.53% |
| 2011 | 132.35 Million TWD | -6.54% |
| 2010 | 141.61 Million TWD | 0.0% |
| 2009 | - TWD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 148.67 Million TWD | 27.14% |
| 2024 Q1 | 136.49 Million TWD | -6.76% |
| 2023 FY | 125.41 Million TWD | 117.37% |
| 2023 Q4 | 125.41 Million TWD | 30.1% |
| 2023 Q1 | 68.63 Million TWD | 18.96% |
| 2023 Q3 | 96.4 Million TWD | 5.81% |
| 2023 Q2 | 91.11 Million TWD | 32.75% |
| 2022 Q2 | 51.26 Million TWD | 8.86% |
| 2022 Q4 | 57.69 Million TWD | 32.24% |
| 2022 Q1 | 47.09 Million TWD | -71.94% |
| 2022 FY | 57.69 Million TWD | -65.62% |
| 2022 Q3 | 43.62 Million TWD | -14.9% |
| 2021 Q2 | 743.28 Million TWD | -2.35% |
| 2021 Q3 | 180.47 Million TWD | -75.72% |
| 2021 Q4 | 167.84 Million TWD | -7.0% |
| 2021 FY | 167.84 Million TWD | -77.45% |
| 2021 Q1 | 761.19 Million TWD | 2.28% |
| 2020 Q3 | 71.92 Million TWD | -4.36% |
| 2020 Q2 | 75.19 Million TWD | -2.59% |
| 2020 Q1 | 77.19 Million TWD | -8.89% |
| 2020 Q4 | 744.23 Million TWD | 934.76% |
| 2020 FY | 744.23 Million TWD | 778.34% |
| 2019 Q2 | 66.96 Million TWD | -5.97% |
| 2019 FY | 84.73 Million TWD | 0.0% |
| 2019 Q3 | 62.54 Million TWD | -6.6% |
| 2019 Q4 | 84.73 Million TWD | 35.48% |
| 2019 Q1 | 71.21 Million TWD | 0.0% |
| 2018 Q3 | - TWD | 0.0% |
| 2018 FY | - TWD | 0.0% |
| 2018 Q4 | - TWD | 0.0% |
| 2018 Q2 | - TWD | 0.0% |
| 2018 Q1 | - TWD | 0.0% |
| 2017 Q4 | - TWD | 0.0% |
| 2017 FY | - TWD | 0.0% |
| 2017 Q3 | - TWD | 0.0% |
| 2017 Q2 | - TWD | 0.0% |
| 2017 Q1 | - TWD | 0.0% |
| 2016 Q1 | - TWD | 0.0% |
| 2016 Q2 | - TWD | 0.0% |
| 2016 Q4 | - TWD | 0.0% |
| 2016 FY | - TWD | 0.0% |
| 2015 Q1 | - TWD | 0.0% |
| 2015 FY | - TWD | 0.0% |
| 2015 Q2 | - TWD | 0.0% |
| 2015 Q4 | - TWD | 0.0% |
| 2015 Q3 | - TWD | 0.0% |
| 2014 Q1 | - TWD | 0.0% |
| 2014 Q2 | - TWD | 0.0% |
| 2014 FY | - TWD | 0.0% |
| 2014 Q4 | - TWD | 0.0% |
| 2014 Q3 | - TWD | 0.0% |
| 2013 Q1 | 117.46 Million TWD | -4.02% |
| 2013 Q2 | 117.46 Million TWD | 0.0% |
| 2013 Q3 | - TWD | -100.0% |
| 2013 Q4 | - TWD | 0.0% |
| 2013 FY | - TWD | -100.0% |
| 2012 Q2 | 127.25 Million TWD | 0.0% |
| 2012 Q3 | 122.38 Million TWD | -3.82% |
| 2012 FY | 122.38 Million TWD | -7.53% |
| 2012 Q4 | 122.38 Million TWD | 0.0% |
| 2011 Q2 | 136.94 Million TWD | 0.0% |
| 2011 FY | 132.35 Million TWD | -6.54% |
| 2011 Q4 | 132.35 Million TWD | 0.0% |
| 2010 Q4 | 141.61 Million TWD | 0.0% |
| 2010 FY | 141.61 Million TWD | 0.0% |
| 2009 FY | - TWD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Apex Biotechnology Corp. | 116.19 Million TWD | -7.937% |
| Sinphar Pharmaceutical Co.,Ltd. | 1.49 Billion TWD | 91.606% |
| Chunghwa Chemical Synthesis & Biotech Co., Ltd. | 700 Million TWD | 82.083% |
| GenMont Biotech Incorporation | 20.11 Million TWD | -523.598% |
| Abnova (Taiwan) Corporation | 2.6 Million TWD | -4721.915% |
| Adimmune Corporation | 1.91 Billion TWD | 93.461% |
| Tanvex BioPharma, Inc. | 1.56 Billion TWD | 92.003% |
| Polaris Group | 352.96 Million TWD | 64.468% |
| Energenesis Biomedical CO.,LTD. | - TWD | -Infinity% |
| UnicoCell Biomed Co., Ltd. | 68.23 Million TWD | -83.8% |
| PELL Bio-Med Technology Co. Ltd. | 147.46 Million TWD | 14.952% |